HF
ANIP icon

HRT Financial’s ANI Pharmaceuticals ANIP Stock Holding History

HRT Financial’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.21M Buy
63,008
+46,176
+274% +$3.7M 0.01% 1128
2026
Q1 		$1.29M Sell
16,832
-5,218
-24% -$407K ﹤0.01% 1902
2025
Q4 		$1.74M Sell
22,050
-17,996
-45% -$1.56M 0.01% 1392
2025
Q3 		$3.67M Buy
+40,046
New +$3.27M 0.01% 822
2025
Q1 		– Sell
-40,283
Closed -$2.23M – 2482
2024
Q4 		$2.23M Buy
+40,283
New +$2.31M 0.01% 692
2024
Q1 		– Sell
-28,634
Closed -$1.58M – 2268
2023
Q4 		$1.58M Buy
+28,634
New +$1.58M 0.01% 764
2023
Q2 		– Sell
-9,245
Closed -$367K – 2424
2023
Q1 		$367K Buy
+9,245
New +$390K ﹤0.01% 1591
2021
Q4 		– Sell
-8,064
Closed -$264K – 3129
2021
Q3 		$264K Buy
+8,064
New +$251K ﹤0.01% 2500

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HRT Financial's ANIP Position: Q2 2026 in Review

HRT Financial increased its ANI Pharmaceuticals (ANIP) stake by 274% in Q2 2026, buying an estimated $3.7M and bringing the position to 63,008 shares worth $5.21M. The position accounts for 0.01% of the portfolio, ranked #1128.

HRT Financial first reported a position in ANIP in Q3 2021 and has held it in 8 quarters since. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • HRT Financial held 63,008 shares of ANI Pharmaceuticals worth $5.21M as of Q2 2026.
  • HRT Financial bought 46,176 ANI Pharmaceuticals shares in Q2 2026, an estimated $3.7M.
  • ANI Pharmaceuticals made up 0.01% of HRT Financial's portfolio in Q2 2026, its #1128 holding.
  • HRT Financial first reported a position in ANI Pharmaceuticals in Q3 2021 and has held it in 8 quarters since.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.